Marsh McLennan’s (NYSE: MMC) subsidiary Oliver Wyman has finalized its purchase of Avascent, a management consulting firm supporting clients across
Oliver Wyman, a Marsh McLennan (NYSE: MMC) subsidiary, has agreed to acquire Avascent, a strategy consulting firm supporting clients across
